6.7 USD
-0.1 (-1.47%)
6.6917 USD
-0.01 (-0.12%)
We assign a fundamental rating of 6 out of 10 to KMDA. KMDA was compared to 533 industry peers in the Biotechnology industry. KMDA has an excellent profitability rating, but there are some minor concerns on its financial health. KMDA scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make KMDA a good candidate for value investing.
1. Profitability
1.1 Basic Checks
KMDA had positive earnings in the past year.
In the past year KMDA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: KMDA reported negative net income in multiple years.
Of the past 5 years KMDA 4 years had a positive operating cash flow.
1.2 Ratios
KMDA has a better Return On Assets (5.16%) than 91.76% of its industry peers.
KMDA's Return On Equity of 7.31% is amongst the best of the industry. KMDA outperforms 92.51% of its industry peers.
With an excellent Return On Invested Capital value of 6.18%, KMDA belongs to the best of the industry, outperforming 92.51% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for KMDA is significantly below the industry average of 18.83%.
The last Return On Invested Capital (6.18%) for KMDA is above the 3 year average (2.98%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.16% | ||
| ROE | 7.31% | ||
| ROIC | 6.18% |
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
1.3 Margins
KMDA has a better Profit Margin (11.21%) than 92.32% of its industry peers.
KMDA's Profit Margin has declined in the last couple of years.
KMDA has a better Operating Margin (14.89%) than 93.45% of its industry peers.
KMDA's Operating Margin has declined in the last couple of years.
KMDA's Gross Margin of 43.62% is fine compared to the rest of the industry. KMDA outperforms 74.16% of its industry peers.
In the last couple of years the Gross Margin of KMDA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.89% | ||
| PM (TTM) | 11.21% | ||
| GM | 43.62% |
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), KMDA is destroying value.
Compared to 1 year ago, KMDA has about the same amount of shares outstanding.
Compared to 5 years ago, KMDA has more shares outstanding
The debt/assets ratio for KMDA is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.20 indicates that KMDA is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.20, KMDA is doing good in the industry, outperforming 69.85% of the companies in the same industry.
The Debt to FCF ratio of KMDA is 0.36, which is an excellent value as it means it would take KMDA, only 0.36 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of KMDA (0.36) is better than 94.94% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that KMDA is not too dependend on debt financing.
KMDA has a Debt to Equity ratio (0.04) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.36 | ||
| Altman-Z | 3.2 |
ROIC/WACC0.73
WACC8.51%
2.3 Liquidity
KMDA has a Current Ratio of 4.00. This indicates that KMDA is financially healthy and has no problem in meeting its short term obligations.
KMDA has a Current ratio (4.00) which is in line with its industry peers.
KMDA has a Quick Ratio of 2.21. This indicates that KMDA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.21, KMDA is doing worse than 70.41% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 2.21 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 28.57% over the past year.
The earnings per share for KMDA have been decreasing by -13.60% on average. This is quite bad
The Revenue has grown by 12.93% in the past year. This is quite good.
KMDA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.82% yearly.
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
Revenue 1Y (TTM)12.93%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
3.2 Future
The Earnings Per Share is expected to grow by 26.83% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 9.34% on average over the next years. This is quite good.
EPS Next Y50.06%
EPS Next 2Y28.87%
EPS Next 3Y26.83%
EPS Next 5YN/A
Revenue Next Year12.07%
Revenue Next 2Y11.09%
Revenue Next 3Y9.34%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 18.61, KMDA is valued on the expensive side.
Based on the Price/Earnings ratio, KMDA is valued cheaply inside the industry as 94.38% of the companies are valued more expensively.
KMDA is valuated rather cheaply when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.
KMDA is valuated correctly with a Price/Forward Earnings ratio of 15.52.
Compared to the rest of the industry, the Price/Forward Earnings ratio of KMDA indicates a rather cheap valuation: KMDA is cheaper than 95.88% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of KMDA to the average of the S&P500 Index (36.59), we can say KMDA is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.61 | ||
| Fwd PE | 15.52 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, KMDA is valued cheaply inside the industry as 97.57% of the companies are valued more expensively.
97.75% of the companies in the same industry are more expensive than KMDA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.23 | ||
| EV/EBITDA | 8.31 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of KMDA may justify a higher PE ratio.
A more expensive valuation may be justified as KMDA's earnings are expected to grow with 26.83% in the coming years.
PEG (NY)0.37
PEG (5Y)N/A
EPS Next 2Y28.87%
EPS Next 3Y26.83%
5. Dividend
5.1 Amount
KMDA has a Yearly Dividend Yield of 2.99%.
Compared to an average industry Dividend Yield of 74.39, KMDA pays a better dividend. On top of this KMDA pays more dividend than 98.88% of the companies listed in the same industry.
KMDA's Dividend Yield is a higher than the S&P500 average which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.99% |
5.2 History
KMDA is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y28.87%
EPS Next 3Y26.83%
6.7
-0.1 (-1.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners10.9%
Inst Owner Change3.21%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap386.46M
Revenue(TTM)160.95M
Net Income(TTM)19.01M
Analysts84.44
Price Target15.05 (124.63%)
Short Float %0.16%
Short Ratio0.74
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.99% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.66%
Min EPS beat(2)1.67%
Max EPS beat(2)45.66%
EPS beat(4)4
Avg EPS beat(4)19.74%
Min EPS beat(4)1.67%
Max EPS beat(4)45.66%
EPS beat(8)7
Avg EPS beat(8)31.91%
EPS beat(12)10
Avg EPS beat(12)19.39%
EPS beat(16)10
Avg EPS beat(16)-93.5%
Revenue beat(2)1
Avg Revenue beat(2)0.35%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)2.19%
Revenue beat(4)1
Avg Revenue beat(4)-0.59%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)2.19%
Revenue beat(8)2
Avg Revenue beat(8)-0.79%
Revenue beat(12)4
Avg Revenue beat(12)-0.43%
Revenue beat(16)5
Avg Revenue beat(16)0.29%
PT rev (1m)-7.81%
PT rev (3m)-7.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)9.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.61 | ||
| Fwd PE | 15.52 | ||
| P/S | 2.28 | ||
| P/FCF | 12.23 | ||
| P/OCF | 9.63 | ||
| P/B | 1.49 | ||
| P/tB | 1.68 | ||
| EV/EBITDA | 8.31 |
EPS(TTM)0.36
EY5.37%
EPS(NY)0.43
Fwd EY6.44%
FCF(TTM)0.55
FCFY8.17%
OCF(TTM)0.7
OCFY10.38%
SpS2.94
BVpS4.51
TBVpS3.98
PEG (NY)0.37
PEG (5Y)N/A
Graham Number6.04
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.16% | ||
| ROE | 7.31% | ||
| ROCE | 7.83% | ||
| ROIC | 6.18% | ||
| ROICexc | 7.78% | ||
| ROICexgc | 8.82% | ||
| OM | 14.89% | ||
| PM (TTM) | 11.21% | ||
| GM | 43.62% | ||
| FCFM | 18.63% |
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.78%
ROICexc(5y)N/A
ROICexgc(3y)8.93%
ROICexgc(5y)N/A
ROCE(3y)3.78%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-12.12%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.72%
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score6
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.36 | ||
| Debt/EBITDA | 0.24 | ||
| Cap/Depr | 58.03% | ||
| Cap/Sales | 5.03% | ||
| Interest Coverage | 35.45 | ||
| Cash Conversion | 100.46% | ||
| Profit Quality | 166.16% | ||
| Current Ratio | 4 | ||
| Quick Ratio | 2.21 | ||
| Altman-Z | 3.2 |
F-Score6
WACC8.51%
ROIC/WACC0.73
Cap/Depr(3y)51.63%
Cap/Depr(5y)66.68%
Cap/Sales(3y)4.57%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
EPS Next Y50.06%
EPS Next 2Y28.87%
EPS Next 3Y26.83%
EPS Next 5YN/A
Revenue 1Y (TTM)12.93%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
Revenue Next Year12.07%
Revenue Next 2Y11.09%
Revenue Next 3Y9.34%
Revenue Next 5YN/A
EBIT growth 1Y50%
EBIT growth 3YN/A
EBIT growth 5Y-2.54%
EBIT Next Year134.93%
EBIT Next 3Y35.01%
EBIT Next 5YN/A
FCF growth 1Y387.49%
FCF growth 3YN/A
FCF growth 5Y7.84%
OCF growth 1Y257.57%
OCF growth 3YN/A
OCF growth 5Y11.54%
KAMADA LTD / KMDA FAQ
Can you provide the ChartMill fundamental rating for KAMADA LTD?
ChartMill assigns a fundamental rating of 6 / 10 to KMDA.
Can you provide the valuation status for KAMADA LTD?
ChartMill assigns a valuation rating of 8 / 10 to KAMADA LTD (KMDA). This can be considered as Undervalued.
Can you provide the profitability details for KAMADA LTD?
KAMADA LTD (KMDA) has a profitability rating of 7 / 10.
Can you provide the financial health for KMDA stock?
The financial health rating of KAMADA LTD (KMDA) is 6 / 10.
Can you provide the expected EPS growth for KMDA stock?
The Earnings per Share (EPS) of KAMADA LTD (KMDA) is expected to grow by 50.06% in the next year.